Evidence map›Paper›PMID 28009003›Full record

ArticleScientific reports2016

Acetyl-11-Keto-β-Boswellic Acid Attenuates Prooxidant and Profibrotic Mechanisms Involving Transforming Growth Factor-β1, and Improves Vascular Remodeling in Spontaneously Hypertensive Rats.

Peijin Shang, Wenxing Liu, Tianlong Liu, Yikai Zhang, Fei Mu, Zhihui Zhu, Lingfei Liang, Xiaohu Zhai, Yi Ding, Yuwen Li and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Advances in Drug Delivery Systems for Boswellic Acids fromInternational journal of molecular sciences · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Preventive nutrition and food science · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Protective Effects of Miswak (Oxidative medicine and cellular longevity · 2018
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Peijin ShangDepartment of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.
Wenxing LiuDepartment of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.
Tianlong LiuDepartment of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.
Yikai ZhangDepartment of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.
Fei MuDepartment of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.
Zhihui ZhuDepartment of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.
Lingfei LiangDepartment of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.
Xiaohu ZhaiDepartment of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.
Yi DingDepartment of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.
Yuwen LiDepartment of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.
Aidong WenDepartment of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.
Xijing Hospital · CNAir Force Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vascular remodeling is an important complication of hypertension with oxidative stress-related profibrotic pathways involved. The transforming growth factor β1 (TGF-β1) has been shown to be a potential target of vasoprotection, and has multiple roles in vascular remodeling. Acetyl-11-Keto-β-Boswellic Acid (AKBA) is one of the active principles of Boswellic acids, and shows antioxidant activity in many diseases. The study is to determine effects of AKBA on systemic oxidative stress of hypertension and vascular remodeling. In the experiments, spontaneously hypertensive rats (SHR) were used. And in vitro, fibroblast was pretreated with AKBA before Ang II stimuli. In the results, treatment of AKBA markedly reduced oxidative stress, and decreased vascular remodeling by restoring vascular wall parameters and improving vascular reactivity. AKBA dramatically reduced TGF-β1 and Smad3 expression, as shown in immunofluorescence and immunohistochemistry. In cultured fibroblast, AKBA decreased intracellular ROS levels. Cell viability and proliferation, as well as migration were inhibited by AKBA. Additionally, treatment of AKBA significantly decreased TGF-β1 secretion in culture supernatant. Expression of TGF-β1, Smad3, P-Smad3 and Smad7 were also decreased by AKBA in fibroblast. In conclusion, AKBA is able to attenuate oxidative stress and profibrotic mechanisms, and improve vascular remodeling in hypertension through TGF-β1/Smad3 pathway.

Indexed as

AnimalsFibrosisGene Expression RegulationHypertensionOxidative StressRatsRats, Inbred SHRRats, Inbred WKYReactive Oxygen SpeciesTransforming Growth Factor beta1TriterpenesVascular Remodelingacetyl-11-ketoboswellic acidReactive Oxygen SpeciesTgfb1 protein, ratTransforming Growth Factor beta1Triterpenes

Identifiers

PMID28009003
PMCPMC5180224
OpenAlexW2562097952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.